Introduction: Pregnant patients become susceptible when their cell-mediated immunity is compromised. During pregnancy, anatomical and physiological alterations such as diaphragm ascension, changes in lung capacity, vasodilation, mucosal edema, and anemia all contribute to susceptibility to hypoxia. Objective: This paper aims to assess outcomes that affect COVID-19 on pregnancy. Patients and Methods: Data were collected retrospectively through reviews of electronic medical records or electronic hospital records and discharge data for all pregnancy patients in different hospitals in Iraq between 4th July 2021 to 9th January 2022 who were >30 years of age or older. These data were designed with two groups. Where the first group was represented with pregnancy patients, explain the women patients have Covid-19 and struggled during the period of Covid-19, while the second group was represented the control group that, which explains the pregnancy group who have Covid-19 and could treated of it. A statistical study was conducted for pregnancy patients using the SPSS program. Results and Discussions: Effects of SARS infection on mothers and their babies. Research shows pregnant women infected with COVID-19 are more likely to develop serious illnesses, including a higher risk of preterm labor and maternal and/or fetal mortality. As a result, this study showed that the BMI in the group of pregnant patients was higher than that of the control group, and the group of pregnant patients was (31 ± 2.1) while the control group was (30 ± 1.9) with a P-value of 0.0492, while the Parity group of pregnant patients was (2.70 ± 1.34) and the control group (1.67 ± 1.13). As for smoking, most of the patients for both groups did not smoke, which included in the pregnant group, 56 (93.33%), while the control group, 57 (95%), with a P-value of 0.0485. In terms of obstetric problems, we saw an increase in the incidence of caesarean delivery and fetal hypoxia corrected after birth but a decrease in the rate of other disorders mentioned in the literature, such as preeclampsia where Preterm birth <37 weeks got 7 (11.67%) in the pregnancy patients, but 5 (8.33%) for the controls patients. As well as, Iatrogenic (<37 weeks) shown high with 6 (10%) in the pregnancy patients and 3 (5%) in the control patients with a p-value of 0.0344. Conclusion: Yet the effects of COVID-19 on fetal development appear to be considerable, and maternal outcomes for women with COVID-19, as well as for asymptomatic women where COVID-19 has a large influence, making this inconsistent Reassuring for expecting moms and those who care for them. Perinatal mortality has increased in the world because of this epidemic, according to research.
COVID-19; Transmission; Gestation; Parity; Diabetes in pregnancy